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Phlegmasia cerulea dolens, or massive 
venous occlusion leading to circulatory tissue 
compromise, is a rare but serious disease 
which is associated with considerable mor- 
bidity and mortality [5,7]. The optimal treat- 
ment for phlegmasia is controversial, not 
only because the disease is uncommon, limit- 
ing the experience of any one group of sur- 
geons, but also because the lack of an ac- 
ceptable animal model has restricted studies 
of the basic pathophysiology of the disease 
[6]. Uncertainty concerning the patho- 
physiology of phlegmasia has led to a variety 
of therapeutic regimens, few of which seem 
to have a sound scientific basis. 
Previous studies in this laboratory [8] have 
shown that venous ligation in the canine hind 
limb, followed by intravenous injection of 
thrombin, produces massive venous occlusion 
which leads to tissue necrosis and a clinical 
picture similar to human phlegmasia. In 
these studies we showed that massive venous 
occlusion resulted in markedly decreased 
tissue blood flow measured by the ‘33Xe 
washout technique [8]. 
The present study utilizes this same model 
of phlegmasia in the canine hind limb to 
study arterial blood flow and arteriovenous 
shunting after venous obstruction. An ag- 
gressive surgical approach is suggested for 
the patient with phlegmasia cerulea dolens. 
METHODS 
Experimental Model 
Adult, conditioned, mongrel dogs, of either 
sex, weighing between 15 and 25 kg were 
used throughout the study. They were anes- 
thetized with intravenous sodium thiamylal 
and intubated. Anesthesia was maintained 
with small intermittent doses of sodium 
thiamylal, and each dog received 2000 ml of 
Ringer’s lactate solution during the opera- 
tion. One femoral artery and vein were 
exposed in each dog through a longitudinal 
incision in the groin under aseptic conditions. 
The femoral vein and all tributaries joining 
the femoral vein just below the inguinal liga- 
ment were ligated. Immediately after liga- 
tion, 1000 USP units of thrombin were in- 
jected intravenously in a distal, dorsal vein in 
the paw. This preparation invariably leads to 
swelling in the hind limb which reaches 
massive proportions in 24 hr. In addition, 
bluish discoloration, ecchymoses, and 
eventual frank skin and muscle necrosis oc- 
curs in all untreated limbs. Ligation of the 
venous system in the canine hind limb 
without thrombin injection results in mild ex- 
tremity swelling which resolves in 24-48 hr 
and does not result in tissue necrosis 181. 
Circulatory Measurements 
Femoral artery flow was monitored with 
an electromagnetic flowmeter (Statham In- 
struments, Inc., Oxnard, Calif.) just prior to 
venous ligation and for approximately 1 hr 
after the induction of phlegmasia. In addi- 
tion, femoral artery flow was evaluated at 2, 
7, and in surviving dogs, 30 days post-oc- 
clusion. In those groups in which therapy 
was attempted 1 day post-occlusion, femoral 
artery flow was measured immediately after 
treatment. 
Muscle blood flow was measured by the 
‘33Xe washout technique, which has been 
described in detail in previous publications [3, 
81. Briefly, the disappearance of 133Xe 
dissolved in saline from a muscle bed is 
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directly related to the nutrient (capillary) 
blood flow to the bed, which in turn is a 
reflection of the arterial blood flow [3] and 
venous pressure [8] present in the muscle bed 
at the time of injection. Five hundred micro- 
curies of 133Xe is injected into an anterior 
tibia1 muscle, and the disappearance of the 
radioactivity is monitored by an external 
scintillation detector, The half-time (TJ+) of 
the disappearance curve is calculated and 
substituted in the formula [3] to yield: 
muscle blood flow (ml/100 g muscle/min) = 
Xenon 133 washout curves were obtained 
just before venous occlusion, immediately 
after occlusion, and at 2 and 7 days post- 
occlusion. In dogs undergoing treatment, 
muscle blood flow was also measured im- 
mediately after institution of treatment. 
Arteriovenous (AV) shunting in the hind 
limb was measured by the method of Lopez- 
Majano et al. [2]. Technetium 99 labeled 
albumin microspheres (3M Co., St. Paul, 
Minn.), 15-25 pm in diameter, were injected 
directly into the femoral artery. Micro- 
spheres passing through AV shunts were 
trapped in pulmonary capillaries, and 
measured by an external scintillation counter 
placed over the right chest. Following this, 
microspheres were injected intravenously to 
derive a value representing 100% shunting 
PI: 
% shunt = (cpm/mCi injected ia x lOO)/ 
(cpm/mCi injected iv) 
where mCi = millicuries of radioactivity 
contained in the intravenous (iv) and intra- 
arterial (ia) doses, and cpm = counts per 
minute measured by the scintillation counter 
placed externally over the right chest. Arte- 
riovenous shunt determinations were made 
just prior to venous occlusion and at 2 and 7 
days post-occlusion. Dogs surviving for 30 
days underwent AV shunt determinations at 
that time. 
Experimental Groups 
Sixteen dogs underwent induction of phleg- 
masia, and were divided into 4 groups: 
Group 1: (4 dogs) received no treatment. 
Group 2: (4 dogs) were treated with sys- 
temic heparin, 100 units/kg/8 hr, starting 24 
hr after the induction of phlegmasia and con- 
tinuing for 7 days post-occlusion. 
Group 3: (4 dogs) underwent bilateral 
lumbar sympathectomy 24 hours post- 
venous occlusion. 
Group 4: (4 dogs) underwent iliofemoral 
venous thrombectomy with a fogarty cath- 
eter 24 hr after venous occlusion. These 
dogs also received systemic heparin post- 
thrombectomy as in Group 2. 
RESULTS 
Within 30 min after venous ligation and 
thrombin injection, all limbs demonstrated 
moderate to severe swelling, with bluish, ec- 
chymotic discoloration. All limbs in Groups 1 
(untreated) and 3 (sympathectomy) pro- 
gressed to frank gangrene, with massive skin 
and muscle necrosis. These limbs remained 
massively swollen throughout the pe- 
riod of observation. Three of the 4 limbs in 
Group 2 (heparin) likewise rapidly pro- 
gressed to gangrene, while the fourth limb 
in Group 3 returned to normal. In contrast, 
all limbs in Group 4 (thrombectomy and 
heparin) recovered completely, with marked 
improvement evident as early as 24 hr post- 
thrombectomy. 
The results of the femoral artery flow mea- 
surements are shown in Table 1. The mean 
pre-occlusion femoral artery flow for all 16 
dogs in the study was 133.4 ml/min. Venous 
ligation and injection of thrombin was asso- 
ciated with an immediate and significant 
(compared to control) reduction in the 
femoral artery flow in all limbs in each group. 
However, 2 days post-occlusion (1 day post- 
treatment in Groups 2, 3, and 4), the femoral 
artery flow was within normal limits despite a 
clinical picture of rapidly progressing 
gangrene in Groups 1, 2, and 3. Seven days 
post-occlusion, all femoral artery flows were 
significantly increased compared to control 
despite frank gangrenous changes in the 
limbs in Groups 1, 2, and 3. However, the 
femoral artery flow returned to normal 30 
days post-occlusion in Group 4. 
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TABLE 1 





2 7 30 
1 133.4 19.8* 148.8 380.0* 
2 133.4 32.5* 130 520.0* 
3 133.4 24.0* 117.5 545.0* 
4 133.4 22.5* 182.5* 245.0* 138.8 
*P < 0.05 compared to control. 
TABLE 2 
Mean Muscle Blood Flow (ml/l00 g muscle/min) Measured by ls3Xe Washout 





Immediately 2 I 
1 11.7 0.75* 2.6* 3.5* 
2 11.7 0.62* 3.5* 4.7* 
3 11.7 0.52* 2.2* 2.2: 
4 11.7 0.50* 12.3 11.4 
*P < 0.05 compared to control. 
The muscle blood flow determinations by 
133Xe washout are shown in Table 2. The con- 
trol value is the mean pre-occlusion muscle 
blood flow for 16 dogs. Venous occlusion 
promptly and significantly (compared to con- 
trol) reduced muscle blood flow in all limbs. 
The muscle blood flow in Groups 1, 2, and 3 
remained significantly lower than control 
values at 2 and 7 days post-occlusion. In con- 
trast, muscle blood flow in Group 4 re- 
turned to normal 1 day post-thrombectomy, 
and remained at the level at 7 days post- 
occlusion. 
The results of the AV shunt determina- 
tions are tabulated in Table 3. The mean con- 
trol AV shunt value was 10.1%. This was 
increased significantly compared to control 
in all groups 2 days post-occlusion. The AV 
shunt measured 7 days post-occlusion re- 
mained significantly increased in Groups 1,2, 
and 3, while in Group 4 this value was not sig- 
nificantly different from control. The 
percentage AV shunt measured 30 days post- 
occlusion remained high, but was not signifi- 
cantly increased over the control value. 
DISCUSSION 
In most instances, the exact etiology of 
human phlegmasia is not known. However, 
almost all cases exhibit the rather abrupt 
onset of massive venous occlusion in the 
lower extremity [I, 41. When left untreated, 
phlegmasia progresses to gangrene in a large 
number of instances, and unfortunately this 
occurs even in 30-509~ of patients aggres- 
sively treated [5]. 
There is little disagreement in the litera- 
ture that anticoagulation with intravenous 
TABLE 3 
Mean Arteriovenous Shunt (96) Determined at Intervals following Venous Occlusion 
Control Post-occlusion (days) 
Group (pre-occlusion) 2 I 30 
1 10.1 41.3* 34.2* 
2 10.1 35.4* 29.8* 
3 10.1 46.6* 35.6* 
4 10.1 29.4* 23.5 21.8 
*P < 0.05 compared to control. 
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heparin and bedrest are the main stays of 
therapy for phlegmasia, but when these mea- 
sures do not result in improvement of the 
patient, there is confusion regarding addi- 
tional therapeutic modalities. Part of this un- 
certainty is due to the lack of an adequate ex- 
perimental model of phlegmasia to evaluate 
proposed therapeutic measures. In addition, 
objective information concerning large and 
nutrient vessel arterial flows are important in 
understanding the pathophysiology of phleg- 
masia and assessing the effectiveness of vari- 
ous modes of therapy. 
The present study utilizes a combination of 
venous ligation and intravenous thrombin to 
produce an experimental model of phleg- 
masia that appears very similar to the human 
disease. The induction of phlegmasia in this 
way produces an immediate and significant 
drop in both large vessel (femoral artery) and 
nutrient (capillary) flow. Subsequently, in 
Groups 1,2, and 3 (untreated, heparin alone, 
and sympathectomy) there was a dramatic 
increase in femoral artery flow while inappro- 
priately the muscle blood flow remained low 
and the limbs became gangrenous. This sug- 
gested that blood was being shunted away 
from the capillary bed, and indeed the mea- 
surement of AV shunting in the limb indi- 
cated a 3- to 4-fold increase in AV shunt flow. 
It would appear that many of the venous col- 
laterals which develop after massive venous 
occlusion reflect non-nutritive AV shunting. 
In sharp contrast, all Group 4 limbs (ve- 
nous thrombectomy plus heparin) recovered 
completely with no muscle necrosis and only 
minor skin breakdown which healed rapidly. 
There was also a rapid return of the muscle 
blood flow to normal 1 day post-throm- 
bectomy, and normal AV shunt values de- 
termined 7 days post-thrombectomy. 
Other potential modes of therapy for 
phlegmasia, such as fasciotomy, vasoactive 
pharmacologic agents, and thrombolytic 
agents are presently being evaluated using 
this same model. 
Based on the data presented, it would ap- 
pear that if bed rest and systemic heparin fail 
to significantly improve a patient with phleg- 
masia cerulea dolens, venous thrombectomy 
in addition to continued heparin might be the 
next logical choice of therapy. Sympathec- 
tomy or heparin alone do not improve nu- 
trient blood flow in experimental phlegmasia. 
The largest shunt values and the lowest 
muscle flows were measured following sym- 
pathectomy. The role of other therapeutic 
modalities in the treatment of phlegmasia 
should be carefully evaluated in terms of 
blood flow measurements. 
SUMMARY 
A model of phlegmasia cerulea dolens in 
the canine hind limb was used to study the 
effects of heparin, sympathectomy, and 
venous thrombectomy plus heparin on limb 
hemodynamics. Only thrombectomy plus 
heparin restored nutrient blood flow and was 
associated with clinical recovery of the limb. 
This experimental model of phlegmasia ap- 
pears to be an excellent tool for testing addi- 
tional modalities of therapy for this serious 
disease. 
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